Skip Navigation LinksHome > July 2014 - Volume 2 - Issue 7 > Advances in Tracheal Reconstruction
Plastic and Reconstructive Surgery - Global Open:
doi: 10.1097/GOX.0000000000000097
Review Article

Advances in Tracheal Reconstruction

Haykal, Siba MD, PhD*†; Salna, Michael BMSc*; Waddell, Thomas K. MD, MSc, PhD*; Hofer, Stefan O. MD, PhD

Open Access
Canada
Article Outline
Collapse Box

Author Information

From the *Latner Thoracic Surgery Research Laboratories, Division of Thoracic Surgery, University Health Network and McEwen Centre for Regenerative Medicine, Toronto, Ontario, Canada; and Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

Received for publication September 29, 2013; accepted March 24, 2014.

Disclosure: The authors have no financial interest to declare in relation to the content of this article. The Article Processing Charge was paid for by the authors.

Siba Haykal, MD, PhD, Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Toronto, Toronto, Ontario M5G 1V7, Canada, E-mail: siba.haykal@utoronto.ca

This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Collapse Box

Abstract

Summary: A recent revival of global interest for reconstruction of long-segment tracheal defects, which represents one of the most interesting and complex problems in head and neck and thoracic reconstructive surgery, has been witnessed. The trachea functions as a conduit for air, and its subunits including the epithelial layer, hyaline cartilage, and segmental blood supply make it particularly challenging to reconstruct. A myriad of attempts at replacing the trachea have been described. These along with the anatomy, indications, and approaches including microsurgical tracheal reconstruction will be reviewed. Novel techniques such as tissue-engineering approaches will also be discussed. Multiple attempts at replacing the trachea with synthetic scaffolds have been met with failure. The main lesson learned from such failures is that the trachea must not be treated as a “simple tube.” Understanding the anatomy, developmental biology, physiology, and diseases affecting the trachea are required for solving this problem.

Back to Top | Article Outline

ANATOMY AND BLOOD SUPPLY

The trachea connects the larynx to the carina, extending from the cricoid cartilage to its bifurcation into the left and right main bronchi. Anteriorly, it is composed of horseshoe-shaped cartilagenous rings making up two thirds of its circumference and posteriorly by a membranous portion connecting the rings.1 In the neck, it is covered by the cervical fascia and infrahyoid muscles, crossed by the isthmus of the thyroid and the jugular venous arch. The carotid sheath and inferior thyroid artery are lateral to the trachea, the esophagus—posterior, and the recurrent laryngeal nerve lies in the groove between the two. In the thorax, it is crossed by the brachiocephalic artery and the left brachiocephalic vein.2

The trachea functions as a conduit for ventilation, clears secretions, warms, humidifies and cleans the air for the respiratory zone, and keeps the airway free of foreign material through coughing and intrinsic defense mechanisms.3,4 The microanatomy of the trachea consists of a pseudostratified ciliated epithelium composed of ciliated cells, goblet cells, basal cells, and neuroendocrine cells4,5 (Fig. 1). The submucosa is rich in elastin, submucosal glands, and smooth muscle. The cartilage is of a hyaline nature.4 The tracheal walls are composed of 15–20 incomplete cartilaginous rings joined together by fibrous tissue and smooth muscle.2 The tracheal lumen is generally ovoid in shape although variations appear even without disease. This lumen flattens anteroposteriorly. Two thirds of the circumference of the trachea is composed of normally C-shaped (or horseshoe-shaped) rings anteriorly while the rest is composed of a flat posterior membranous wall. This posterior wall is made of a thin membrane supported by the trachealis muscle.3 There are about 2 rings per centimeter of trachea (see Figure 2 for photograph of a human trachea).

Fig. 1
Fig. 1
Image Tools
Fig. 2
Fig. 2
Image Tools

The trachea’s blood supply comes from its lateral pedicles, vessels which originate from the inferior thyroid, subclavian, supreme intercostal, internal thoracic, innominate, and superior and middle bronchial arteries.6 All of these vessels interconnect along the lateral surface and form important longitudinal vascular anastomoses. The lateral and anterior tracheal walls receive their blood supply from transverse segmental vessels which extend from these 2 lateral longitudinal networks and run between the cartilage rings. The transverse vessels feed capillary beds beneath the endotracheal mucosa that nourish the cartilage by diffusion. The esophageal arteries and their subdivisions supply the posterior membranous portion only.6 The trachea’s intricate blood supply makes devascularization easy and reconstruction especially challenging.

Back to Top | Article Outline

TRACHEAL REPLACEMENTS

Indications

The indications for tracheal replacement are lesions that cannot be resected and reconstructed safely with end-to-end anastomosis or long-segment congenital stenosis, which cannot be effectively managed with slide or patch tracheoplasty. Acquired lesions include malignancy, traumatic injury, and subglottic or tracheal stenosis. The general limits for safe resection are about one half of the tracheal length in adults and one third in small children. Very lengthy lesions that cannot be safely removed and reconstructed primarily are managed palliatively with long-term T-tubes or stents. The clinical course of these patients is usually complicated with multiple infections and frequent hospital admissions. Therefore, a safe and dependable tracheal replacement remains an important unmet need.

Back to Top | Article Outline
Requirements

The requirements for tracheal replacements are to be laterally rigid but longitudinally flexible, to have a surface composed of ciliated respiratory epithelium (although some authors have considered this not essential), or at least to have a surface which facilitates epithelial resurfacing. They must also be biocompatible, nontoxic, nonimmunogenic, and noncarcinogenic. They must not dislocate or erode over time, avoid accumulation of secretions, resist bacterial colonization, and must be permanent.

Back to Top | Article Outline
Approaches

The approaches used for tracheal replacement include stents and synthetic prostheses and scaffolds and are summarized in Table 1. The use of autologous tissues in combination with synthetic material is summarized in Table 2. The most interesting recent advances in the field of tracheal reconstruction pertain to tracheal transplantation and tissue engineering and are described in further detail.

Table 1
Table 1
Image Tools
Table 2
Table 2
Image Tools
Back to Top | Article Outline

TRACHEAL TRANSPLANTATION

Nonrevascularized Grafts
Autografts

Tracheal excision and immediate orthotopic reimplantation (fresh autograft) often fail due to a delay in revascularization.46,72–75 However, this depends on the length of the autograft.74,76 Despite possible survival in short segments, the cartilage eventually resorbed and the segment was replaced with fibrous tissue.77 In longer segments, dissolution, stenosis, and obstruction followed due to loss of blood supply.74 A new experimental technique using composite cervical skin and a costal cartilage flap has shown some promise over long segments although long-term follow-up is required.78

Back to Top | Article Outline
Allografts

Fresh tracheal allografts without immunosuppression will lead to rejection.35,76,79,80 Rejection of fresh allografts of any length occurs even with immunosuppression, in the absence of revascularization.26,63,74,77 All these grafts necrose, liquefy, or result in stenosis. Preserved and devascularized allografts also failed due to cartilage resorption, scar replacement, fibrosis, and eventual complete obstruction.46,76,81,82 Cryopreserved allografts for small window defects83 and short segments84 reepithelialized but failed over longer lengths.85 Patients transplanted with chemically fixed allografts for noncircumferential defects required multiple subsequent operations with a decannulation rate of only 60% in children and even lower in the adult population.86 The literature implies that blood supply is critical for successful transplantation.

Back to Top | Article Outline
Vascularized Grafts
Autografts

Revascularization of fresh short-segment tracheal autografts was performed using omentum,87–89 intercostal muscle,90 deltopectoral muscle,91 pectoralis major muscle,92 free costal cartilage grafts,93 chondromuscular flaps,94 musculofascial flaps,95 or other vascular pedicles such as the latissimus dorsi.59,60 Omental flaps longer than 4 cm frequently resulted in ischemic tracheal segments and stenosis.96 Preliminary implantation into a vascularized tissue or flap with delayed transfer into the defect has proven to be more successful.38

Back to Top | Article Outline
Allografts

Nontracheal allografts, such as fresh and cryoperserved allogeneic aorta, required no immunosuppression and had no graft rejection in most cases. However, aortic grafts were deemed unsuitable for tracheal replacement because of failure to regenerate and incorporate recipient tissue, requiring stenting and/or retransplantation.97,98

In tracheal allografts, the epithelium is the major site of antigenicity and removal with a detergent99 or irradiation100 was thought to prevent rejection.101–104 Reepithelialization occurred by migration from the host epithelium105 while the chondrocytes remained of donor origin.106 However, complete epithelial regeneration failed and allografts were eventually rejected.107 Other studies focused on providing immunosuppression, which allows for initial revascularization of a heterotopically transplanted graft to improve success of orthotopic allotransplantation.108,109

The first clinical tracheal allotransplantation was reported in 1979, where a donor trachea was first implanted heterotopically under the sternocleidomastoid muscle and pedicled orthotopically after 3 weeks.110 No immunosuppression was required, and short-term integration with surrounding tissue and reepithelialization was achieved. Another case, later performed with omental revascularization and immunosuppression, eventually led to necrosis and stenosis requiring stent placement.111

Back to Top | Article Outline
Direct Revascularization

The blood supply to the trachea makes it challenging for direct revascularization. A composite graft composed of a thyrotracheal graft with anastomoses of the thyroid artery to the common carotid artery112 has been attempted. Venous anastomosis was also required to prevent soft-tissue necrosis.113,114 Long-term results have not been reported.

There is also an expanding role for free flaps to allow for revascularization of autografts and allografts. Their long-term outcomes for large tracheal defects have been reviewed by Yu et al.115 The free flaps used include radial forearm flap,115118 anterolateral thigh flap,119,120 sternohyoid muscle,121 and a saphenous corticoperiostal flap.122

Clinically, the transplantation of a fresh laryngeal allograft was performed to replace a stenotic larynx following a motorcycle accident. This allograft also included a 5-ring segment of trachea, thyroid, parathyroids, a portion of the attached pharyngeal wall, both superior laryngeal nerves, and the right recurrent nerve. Arterial, venous, and neural anastomoses were performed, and perfusion was established early in the procedure. Over time, the patient regained vocal cord function and normal deglutition. Despite one episode of rejection, health and function were good at 40 months, with continued immunosuppression.123

In 2010, a donor tracheal allograft was initially heterotopically transplanted under the forearm fascia to allow for indirect revascularization in an immunosuppressed patient. The donor posterior membranous part necrosed and was replaced with the recipient’s buccal mucosa. The graft was subsequently moved to the orthotopic position, by which time the patient no longer required immunosuppression. The graft was fully lined with both donor and recipient epithelium and had viable donor tracheal cartilage surrounded by recipient blood vessels. It was harvested on a radial forearm free flap and inserted into a 4.5-cm defect.124 Recently, they have moved toward the use of autologous cells as reepithelialization was found to be very slow with the use of a buccal mucosa (unpublished results).

Back to Top | Article Outline

TRACHEAL TISSUE ENGINEERING

The long-term risks of chronic immunosuppression and their contraindications in malignant disease have led to interest in tissue-engineering techniques.

The use of the term “tissue engineering” implies the replacement of tissues and organs by isolation and culture of cells outside the body, which are seeded later into a biocompatible scaffold before implantation. The 3 components required for tissue engineering are cells, scaffolds, and bioreactors.

Back to Top | Article Outline
Cells
Epithelial Cells

In the trachea, resident epithelial cells are located along the basal layer. These cells can be isolated, cultured, and differentiated in vitro.125–128 Nontracheal exogenous cells that can be used for epithelial regeneration include embryonic stem cells, induced pluripotent stem cells, and cells from mesenchymal origin such as mesenchymal stem cells, human amniotic fluid stem cells, and umbilical blood cord–derived stem cells.129

Back to Top | Article Outline
Chondrocytes

Regeneration of endogenous cartilage can be stimulated in vivo by implantation of a gelatin sponge slowly releasing basic fibroblast growth factor130,131 or bone morphogenetic protein 2.132,133 The regenerated cartilage is of fibrous rather than hyaline nature. Autologous sources of chondrocytes include the nose, ribs, and ear, and these have been isolated and expanded in vitro in cell flasks and in a 3-dimensional culture system.134–138 Despite the formation of a well-vascularized neotrachea, these scaffold-free constructs showed signs of mechanical failure. Allogeneic chondrocytes have also been used for the repair of joint cartilage and are intriguing due to their low antigenicity.139,140

The exogenous use of autologous stem/progenitor cells has been considered as a safer alternative and a better option for cell amplification. These include autologous adipose-derived stem cells and mesenchymal stromal cells and induced pluripotent stem cells.141

Back to Top | Article Outline
Scaffolds
Synthetic

The advantages of synthetic scaffolds include tailoring of size and shape and the ability to control their properties such as strength, degradation time, porosity, and microstructure. However, they lack the macro- and microanatomic structures of natural scaffolds. There are many potential materials.142–146 The biodegraded molecules from polyglycolic acid led to a low pH environment and excited a vigorous inflammatory response when transplanted.147 Hydrogels also have a slow degradation rate and noncontrolled long-term biologic response.148

Recently, a long-segment circumferential trachea along with the carina and the main bronchi was fabricated from a nanocomposite polymer (POSS) covalently bonded to polyurethane (PCU). The casted form was made into the cartilage “U” shaped rings, and the coagulated form was used for the “connective” tracheal part. It was shown to support recipient progenitor cells and was used clinically.149 Long-term remodeling and outcome remain unknown.

Back to Top | Article Outline
Natural and Decellularized

Natural and decellularized scaffolds are thought to be advantageous because they support adhesion, proliferation, and differentiation of many different cell types.150 They are composed of extracellular matrix material such as collagens,42,134,137,151,152 fibrin/hyaluronic acid,135 and other glycosaminoglycan products. The limitations are their lack of consistency, structure malleability, and biodegradability.

In 2004, a tissue-engineered tracheal patch was used as a bioartificial construct for a tracheal defect in a 58-year-old man.153 It was composed of autologous muscle, fibroblasts, and a collagen matrix from a decellularized porcine proximal jejunum segment. This scaffold was incubated for 3 weeks in a bioreactor before transplantation. After 12 weeks, the bioartificial patch had a ciliated pseudostratified epithelium and was integrated into the adjacent airway.153

In 2008, a 30-year-old woman was the recipient of a decellularized allogeneic trachea for replacement of her left main bronchus. This scaffold required 25 cycles of decellularization based on the absence of major histocompatibility complex markers within the cartilage.154 The scaffold was then recellularized in a bioreactor with primary autologous epithelial cells and mesenchymal stem cell–derived chondrocytes. The patient did not develop antidonor antibodies and did not receive immunosuppressive therapy. The procedure has since been modified to use the recipient’s body as a bioreactor: seeding the scaffold intraoperatively with autologous respiratory epithelial and bone marrow–derived mononuclear cells.155 This in vivo tissue-engineered approach was used in a case series of 9 pediatric and adult patients with benign and malignant diseases on a compassionate basis. No graft-related mortality was reported after follow-up of 12–42 months, with all bioengineered grafts remaining vascularized and lined with healthy respiratory mucosa. However, partial collapse of the scaffolds was noted in 3 patients.156,157 The collapse was thought to be due to degradation of the extracellular matrix architecture and a decrease in the mechanical and angiogenic properties that occurs after long-term storage.158 The group felt that decellularized matrices led to unpredictable results and has since moved on to use an artificial tracheal and bronchial scaffold from a nanocomposite polymeric material.149

Back to Top | Article Outline
Bioreactors

Bioreactors are laboratory tissue-culture devices that provide a controllable, mechanically active environment and can be used to study and improve tissue-engineered structures159 (Figure 3). They enable the cell seeding process, allow for proliferation on a large scale and production of 3D constructs,160,161 and provide an optimal physiological environment for cell adhesion, growth, and differentiation by provision of flow of nutrient media and mechanical stimulation mimicking conditions of growing organ.162 Their operational conditions may be manipulated (such as pH, temperature, oxygen tension, and nutrient supply). Several bioreactors have been described for tracheal tissue engineering,163–167 and a commercial version of this bioreactor launched by Harvard Bioscience currently exists and was used for the first human tissue-engineered tracheal replacement.154 Following the first clinical transplantation, the authors turned to in situ tissue engineering mentioning long-lasting seeding period, high costs, potential risks of cell differentiation instability, and contamination as bottlenecks to integration of bioreactor-seeded tracheas.168

Fig. 3
Fig. 3
Image Tools
Back to Top | Article Outline

CONCLUSIONS

The anatomical features of the trachea, which include its proximity to major vessels, segmental blood supply, anteroposterior heterogeneity, lateral rigidity, and longitudinal flexibility, make it more complex than a simple conduit. The presence of different tissues, including respiratory epithelium, submucosa, cartilage, and blood vessels, makes reconstruction of the trachea particularly challenging. The attempts that have shown the greatest promise have used tissue-engineered techniques with decellularized allografts. However, there continues to be some significant challenges with biological scaffolds composed of the extracellular matrix particularly related to revascularization. Plastic and reconstructive microsurgeons can significantly contribute to this field by combining free-flap techniques to allow for initial revascularization of these scaffolds followed by a delayed reconstruction, thus providing a novel technique for reconstruction of circumferential long-segment tracheal defects.

Back to Top | Article Outline

REFERENCES

1. Laroia AT, Thompson BH, Laroia ST, et al. Modern imaging of the tracheo-bronchial tree. World J Radiol. 2010;2:237–248

2. Burdett E, Mitchell V. Anatomy of the larynx, trachea and bronchi. Anaesth Intensive Care Med.. 2008;9:329–333

3. Farmer S, Hay D The Airway Epithelium: Physiology, Pathophysiology, and Pharmacology. 1991 New York M. Dekker

4. Weinberger SE Principles of Pulmonary Medicine. 20044th ed. Philadelphia, PA W. B. Saunders

5. Rock JR, Randell SH, Hogan BL. Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech. 2010;3:545–556

6. Salassa JR, Pearson BW, Payne WS. Gross and microscopical blood supply of the trachea. Ann Thorac Surg. 1977;24:100–107

7. Zwischenberger JB, Wittich GR, vanSonnenberg E, et al. Airway simulation to guide stent placement for tracheobronchial obstruction in lung cancer. Ann Thorac Surg. 1997;64:1619–1625
8. Saito Y, Imamura H. Airway stenting. Surg Today. 2005;35:265–270

9. Wood DE. Airway stenting. Chest Surg Clin N Am. 2001;11:841–860

10. Liu KS, Liu YH, Peng YJ, et al. Experimental absorbable stent permits airway remodeling. J Thorac Cardiovasc Surg. 2011;141:463–468

11. Ng AH, Ng NS, Zhu GH, et al. A fully degradable tracheal stent: in vitro and in vivo characterization of material degradation. J Biomed Mater Res B Appl Biomater. 2012;100:693–699

12. Sato T, Araki M, Nakajima N, et al. Biodegradable polymer coating promotes the epithelization of tissue-engineered airway prostheses. J Thorac Cardiovasc Surg. 2010;139:26–31

13. Cotton BH, Hills B, Penido JR. Resection of the trachea for carcinoma; report of two cases. J Thorac Surg. 1952;24:231–245

14. Beattie EJ Jr, Blades B, Keshishian JM. Tracheal reconstruction. J Thorac Surg. 1956;32:707–725; discussion 725–727
15. Neville WE, Bolanowski JP, Kotia GG. Clinical experience with the silicone tracheal prosthesis. J Thorac Cardiovasc Surg. 1990;99:604–612; discussion 612–613
16. Toomes H, Mickisch G, Vogt-Moykopf I. Experiences with prosthetic reconstruction of the trachea and bifurcation. Thorax. 1985;40:32–37

17. Clagett OT, Moersch HJ, Grindlay JH. Intrathoracic tracheal tumors: development of surgical technics for their removal. Ann Surg. 1952;136:520–532

18. Atamanyuk MY, Melrose DG. The treatment of circumferential defects of the trachea. Br J Surg. 1965;52:59–65

19. Ekestrom S, Carlens E. Teflon prosthesis in tracheal defects in man. Acta Chir Scand Suppl. 1959(Suppl 245):71–75
20. Hirano M, Yoshida T, Sakaguchi S. Hydroxylapatite for laryngotracheal framework reconstruction. Ann Otol Rhinol Laryngol. 1989;98:713–717

21. Triglia JM, Scheiner C, Gouvernet J, et al. Hydroxyapatite in experimental laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg. 1993;119:87–91

22. Grillo HC. Surgery of the Trachea and Bronchi. 2004 BC Decker: Hamilton, Ontario, Canada
23. Wilhelm DL. Regeneration of tracheal epithelium. J Pathol Bacteriol. 1953;65:543–550

24. Bailey BJ, Kosoy J. Observations in the development of tracheal prostheses and tracheal transplantation. Laryngoscope. 1970;80:1553–1565

25. Beall AC Jr, Harrington OB, Greenberg SD, et al. Tracheal replacement with heavy Marlex mesh. Circumferential replacement of the cervical trachea. Arch Surg. 1962;84:390–396

26. Daniel RA Jr. The regeneration of defects of the trachea and bronchi; an experimental study. J Thorac Surg. 1948;17:335–349

27. Greenberg SD, Willms RK. Regeneration of respiratory epithelium. An experimental study in dogs. Arch Pathol. 1962;73:53–58

28. Moghissi K. Tracheal reconstruction with a prosthesis of Marlex mesh and pericardium. J Thorac Cardiovasc Surg. 1975;69:499–506

29. Morfit HM, Neerken AJ, Prevedel A, et al. Sleeve resections of the trachea; experimental studies on regenerative capacity and principles of reconstruction and repair. AMA Arch Surg. 1955;70:654–661

30. Pearson FG, Henderson RD, Gross AE, et al. The reconstruction of circumferential tracheal defects with a porous prosthesis. An experimental and clinical study using heavy Marlex mesh. J Thorac Cardiovasc Surg. 1968;55:605–616

31. Poticha SM, Lewis FJ. Experimental replacement of the trachea. J Thorac Cardiovasc Surg. 1966;52:61–67

32. Sekine T, Nakamura T, Matsumoto K, et al. Carinal reconstruction with a Y-shaped collagen-conjugated prosthesis. J Thorac Cardiovasc Surg. 2000;119:1162–1168

33. Shaw RR, Aslami A, Webb WR. Circumferential replacement of the trachea in experimental animals. Ann Thorac Surg. 1968;5:30–35

34. Wykoff TW. A preliminary report on segmental tracheal prosthetic replacement in dogs. Laryngoscope. 1973;83:1072–1077

35. Beigel A, Steffens-Knutzen R, Müller B, et al. Tracheal transplantation. III. Demonstration of transplantation antigens on the tracheal mucosa of inbred rat strains. Arch Otorhinolaryngol. 1984;241:1–8

36. Cahan WG. Carcinoma of intrathoracic trachea: excision and repair by tantalum gauze-fascia lata graft; report of a case. J Thorac Surg. 1952;23:513–527

37. Li J, Xu P, Chen H. Successful tracheal autotransplantation with two-stage approach using the greater omentum. Ann Thorac Surg. 1997;64:199–202

38. Li J, Xu P, Chen H, et al. Improvement of tracheal autograft survival with transplantation into the greater omentum. Ann Thorac Surg. 1995;60:1592–1596

39. Nelson RJ, Goldberg L, White RA, et al. Neovascularity of a tracheal prosthesis/tissue complex. J Thorac Cardiovasc Surg. 1983;86:800–808

40. Tatekawa Y, Kawazoe N, Chen G, et al. Tracheal defect repair using a PLGA-collagen hybrid scaffold reinforced by a copolymer stent with bFGF-impregnated gelatin hydrogel. Pediatr Surg Int. 2010;26:575–580

41. Teramachi M, Okumura N, Nakamura T, et al. Intrathoracic tracheal reconstruction with a collagen-conjugated prosthesis: evaluation of the efficacy of omental wrapping. J Thorac Cardiovasc Surg. 1997;113:701–711

42. Yamashita M, Kanemaru S, Hirano S, et al. Tracheal regeneration after partial resection: a tissue engineering approach. Laryngoscope. 2007;117:497–502

43. Scherer MA, Ascherl R, Geissdörfer K, et al. Experimental bioprosthetic reconstruction of the trachea. Arch Otorhinolaryngol. 1986;243:215–223

44. Bujía J, Wilmes E, Hammer C. [Immunologic behavior of human tracheal transplants]. Laryngorhinootologie. 1992;71:353–358

45. Grillo HC, Mckhann CF. The acceptance and evolution of dermal homografts freed of viable cells. Transplantation. 1964;2:48–59

46. Bjork VO, Rodriguez LE. Reconstruction of the trachea and its bifurcation; an experimental study. J Thorac Surg. 1958;35:596–603

47. Jacobs JP, Elliott MJ, Haw MP, et al. Pediatric tracheal homograft reconstruction: a novel approach to complex tracheal stenoses in children. J Thorac Cardiovasc Surg. 1996;112:1549–1558; discussion 1559–1560
48. Elliott MJ, Haw MP, Jacobs JP, et al. Tracheal reconstruction in children using cadaveric homograft trachea. Eur J Cardiothorac Surg. 1996;10:707–712

49. Davis JS. II. The transplantation of free flaps of fascia: an experimental study. Ann Surg. 1911;54:734–748

50. Swift EA, Grindlay JH, Clagett OT. The repair of tracheal defects with fascia and tantalum mesh: an experimental study. J Thorac Surg. 1952;24:482–492

51. Michelson E, Solomon R, Maun L, et al. Experiments in tracheal reconstruction. J Thorac Cardiovasc Surg. 1961;41:748–759

52. Fonkalsrud EW, Plested WG. Tracheobronchial reconstruction with autologous periosteum. J Thorac Cardiovasc Surg. 1966;52:666–674

53. Cohen RC, Filler RM, Konuma K, et al. A new model of tracheal stenosis and its repair with free periosteal grafts. J Thorac Cardiovasc Surg. 1986;92:296–304

54. Eckersberger F, Moritz E, Wolner E. Circumferential tracheal replacement with costal cartilage. J Thorac Cardiovasc Surg. 1987;94:175–180

55. Farkas LG, Farmer AW, McCain WG, et al. Replacement of a tracheal defect in the dog by a preformed composite graft. A later report. Plast Reconstr Surg. 1972;50:238–241

56. Sabás AA, Uez JB, Rojas O, et al. Replacement of the trachea with dura mater. Experimental work. J Thorac Cardiovasc Surg. 1977;74:761–765

57. Barker WS, Litton WB. Bladder osteogenesis aids tracheal reconstruction. Arch Otolaryngol. 1973;98:422–425

58. Jones RE, Morgan RF, Marcella KL, et al. Tracheal reconstruction with autogenous jejunal microsurgical transfer. Ann Thorac Surg. 1986;41:636–638

59. Ishida I, Oura H, Niikawa H, et al. Non-circumferential tracheal resection with muscle flap reconstruction for adenoid cystic carcinoma. Gen Thorac Cardiovasc Surg. 2012;60:603–606

60. Jana T, Khabbaz E, Bush CM, et al. The body as a living bioreactor: a feasibility study of pedicle flaps for tracheal transplantation. Eur Arch Otorhinolaryngol. 2013;270:181–186

61. Akl BF, Mittelman J, Smith DE, et al. A new method of tracheal reconstruction. Ann Thorac Surg. 1983;36:265–269

62. Kaneko K, Sakaguchi K, Takano A, et al. Tracheal reconstruction using S-shaped skin flaps and a conchal cartilage graft. Ann Thorac Surg. 2011;92:e111–e112

63. Edgerton MT, Zovickian A. Reconstruction of the trachea and infraglottic larynx. Plast Reconstr Surg (1946). 1954;13:167–192

64. Grillo HC, Dignan EF, Miura T. Experimental reconstruction of cervical trachea after circumferential resection. Surg Gynecol Obstet. 1966;122:733–738

65. Serrano A, Ortiz-Monasterio F, Andrade-Pradillo J. Reconstruction of the cervical trachea. Reconstruction of the cervical trachea. A technique to obtain a permanently patent airway. Plast Reconstr Surg Transplant Bull. 1959;24:333–340
66. Anoosh F, Hodjati H, Dehghani S, et al. Tracheal replacement by autogenous aorta. J Cardiothorac Surg. 2009;4:23

67. Martinod E, Seguin A, Pfeuty K, et al. Long-term evaluation of the replacement of the trachea with an autologous aortic graft. Ann Thorac Surg. 2003;75:1572–1578; discussion 1578
68. Azorin JF, Bertin F, Martinod E, et al. Tracheal replacement with an aortic autograft. Eur J Cardiothorac Surg. 2006;29:261–263

69. Ein SH, Friedberg J, Williams WG, et al. Tracheoplasty—a new operation for complete congenital tracheal stenosis. J Pediatr Surg. 1982;17:872–878

70. Fonkalsrud EW, Martelle RR, Maloney JV Jr. Surgical treatment of tracheal agenesis. J Thorac Cardiovasc Surg. 1963;45:520–525

71. Fonkalsrud EW, Sumida S. Tracheal replacement with autologous esophagus for tracheal stricture. Arch Surg. 1971;102:139–142

72. Borrie J, Redshaw NR. Prosthetic tracheal replacement. J Thorac Cardiovasc Surg. 1970;60:829–835

73. Strandness DE Jr, Gustafson IJ, Payne JT. Surgical resection of the thoracic trachea: an experimental study in dogs. J Thorac Surg. 1957;34:269–277

74. Neville WE, Bolanowski PJ, Soltanzadeh H. Homograft replacement of the trachea using immunosuppression. J Thorac Cardiovasc Surg. 1976;72:596–601

75. Nakanishi R, Shirakusa T, Takachi T. Omentopexy for tracheal autografts. Ann Thorac Surg. 1994;57:841–845

76. Pacheco CR, Rivero O, Porter JK. Experimental reconstructive surgery of the trachea. J Thorac Surg. 1954;27:554–564

77. Aronstam EM, Nims RM, Winn DF Jr. Studies in segmental replacement of the thoracic trachea. J Surg Res. 1961;1:108–110

78. Fabre D, Singhal S, De Montpreville V, et al. Composite cervical skin and cartilage flap provides a novel large airway substitute after long-segment tracheal resection. J Thorac Cardiovasc Surg. 2009;138:32–39

79. Bujia J, Wilmes E, Hammer C, et al. Tracheal transplantation: demonstration of HLA class II subregion gene products on human trachea. Acta Otolaryngol. 1990;110:149–154

80. Kalb TH, Chuang MT, Marom Z, et al. Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol. 1991;4:320–329

81. Jackson TL, O’Brien EJ, Tuttle W, et al. The experimental use of homogenous tracheal transplants in the restoration of continuity of the tracheobronchial tree. J Thorac Surg. 1950;20:598–612; passim

82. Davies OG, Edmiston JM, McCorkle HJ. The repair of experimental tracheal defects with fresh and preserved homologous tracheal grafts. J Thorac Surg. 1952;23:367–376

83. Messineo A, Filler RM, Bahoric A, et al. Repair of long tracheal defects with cryopreserved cartilaginous allografts. J Pediatr Surg.. 1992;27:1131–1134; discussion 1134–1135

84. Inutsuka K, Kawahara K, Takachi T, et al. Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs. Ann Thorac Surg. 1996;62:1480–1484

85. Lenot B, Macchiarini P, Dulmet E, et al. Tracheal allograft replacement. An unsuccessful method. Eur J Cardiothorac Surg. 1993;7:648–652

86. Propst EJ, Prager JD, Meinzen-Derr J, et al. Pediatric tracheal reconstruction using cadaveric homograft. Arch Otolaryngol Head Neck Surg. 2011;137:583–590

87. Hirata T, Yamazaki F, Fukuse T, et al. Omentopexy for revascularization of free tracheal grafts in rats. Thorac Cardiovasc Surg. 1992;40:178–181

88. Messineo A, Filler RM, Bahoric B, et al. Successful tracheal autotransplantation with a vascularized omental flap. J Pediatr Surg. 1991;26:1296–1300

89. Borro JM, Chirivella M, Vila C, et al. Successful revascularization of large isolated tracheal segments. Eur J Cardiothorac Surg.. 1992;6:621–623; discussion 624
90. Fell SC, Mollenkopf FP, Montefusco CM, et al. Revascularization of ischemic bronchial anastomoses by an intercostal pedicle flap. J Thorac Cardiovasc Surg. 1985;90:172–178

91. Kumaran S, Nambi GI, Kingsly Paul M, et al. Post-electrical-burn tracheal-defect reconstruction with pre-fabricated deltopectoral flap—a case report. J Plast Reconstr Aesthet Surg. 2009;62:e93–e94

92. He J, Xu X, Chen M, et al. Novel method to repair tracheal defect by pectoralis major myocutaneous flap. Ann Thorac Surg. 2009;88:288–291

93. Nakahira M, Nakatani H, Takeuchi S, et al. Safe reconstruction of a large cervico-mediastinal tracheal defect with a pectoralis major myocutaneous flap and free costal cartilage grafts. Auris Nasus Larynx. 2006;33:203–206

94. Guerrissi JO, Guerrissi JA, Miranda MG. Functional reconstruction of the trachea: prelaminated chondromuscular flap. J Craniofac Surg. 2009;20:868–871

95. Masuda M, Kamizono K, Ejima M, et al. Tracheal reconstruction with a modified infrahyoid myocutaneous flap. Laryngoscope. 2012;122:992–996

96. Nakanishi R, Shirakusa T, Mitsudomi T. Maximum length of tracheal autografts in dogs. J Thorac Cardiovasc Surg. 1993;106:1081–1087

97. Tsukada H, Ernst A, Gangadharan S, et al. Tracheal replacement with a silicone-stented, fresh aortic allograft in sheep. Ann Thorac Surg. 2010;89:253–258

98. Wurtz A, Hysi I, Zawadzki C, et al. Construction of a tube-shaped tracheal substitute using fascial flap-wrapped revascularized allogenic aorta. Eur J Cardiothorac Surg. 2012;41:663–668

99. Liu Y, Nakamura T, Yamamoto Y, et al. Immunosuppressant-free allotransplantation of the trachea: the antigenicity of tracheal grafts can be reduced by removing the epithelium and mixed glands from the graft by detergent treatment. J Thorac Cardiovasc Surg. 2000;120:108–114

100. Yokomise H, Inui K, Wada H, et al. High-dose irradiation prevents rejection of canine tracheal allografts. J Thorac Cardiovasc Surg. 1994;107:1391–1397

101. Balderman SC, Weinblatt G. Tracheal autograft revascularization. J Thorac Cardiovasc Surg. 1987;94:434–441

102. Tojo T, Niwaya K, Sawabata N, et al. Tracheal replacement with cryopreserved tracheal allograft: experiment in dogs. Ann Thorac Surg. 1998;66:209–213

103. Mukaida T, Shimizu N, Aoe M, et al. Experimental study of tracheal allotransplantation with cryopreserved grafts. J Thorac Cardiovasc Surg. 1998;116:262–266

104. Kawahara K, Inutsuka K, Hiratsuka M, et al. Tracheal transplantation for carinal reconstruction in dogs. J Thorac Cardiovasc Surg. 1998;116:397–401

105. Mukaida T, Shimizu N, Aoe M, et al. Origin of regenerated epithelium in cryopreserved tracheal allotransplantation. Ann Thorac Surg. 1998;66:205–208

106. Tojo T, Kitamura S, Gojo S, et al. Epithelial regeneration and preservation of tracheal cartilage after tracheal replacement with cryopreserved allograft in the rat. J Thorac Cardiovasc Surg. 1998;116:624–627

107. Moriyama H, Sasajima T, Hirata S, et al. Revascularization of canine cryopreserved tracheal allografts. Ann Thorac Surg. 2000;69:1701–1706

108. Delaere PR, Liu ZY, Hermans R, et al. Experimental tracheal allograft revascularization and transplantation. J Thorac Cardiovasc Surg. 1995;110:728–737

109. Delaere PR, Liu Z, Sciot R, et al. The role of immunosuppression in the long-term survival of tracheal allografts. Arch Otolaryngol Head Neck Surg. 1996;122:1201–1208

110. Rose KG, Sesterhenn K, Wustrow F. Tracheal allotransplantation in man. Lancet. 1979;1:433

111. Levashov YuN, Yablonsky PK, Cherny SM, et al. One-stage allotransplantation of thoracic segment of the trachea in a patient with idiopathic fibrosing mediastinitis and marked tracheal stenosis. Eur J Cardiothorac Surg. 1993;7:383–386

112. Khalil-Marzouk JF. Allograft replacement of the trachea. Experimental synchronous revascularization of composite thyrotracheal transplant. J Thorac Cardiovasc Surg. 1993;105:242–246

113. Macchiarini P, Lenot B, de Montpreville V, et al. Heterotopic pig model for direct revascularization and venous drainage of tracheal allografts. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg. 1994;108:1066–1075

114. Macchiarini P, Mazmanian GM, de Montpréville VT, et al. Maximal preservation time of tracheal allografts. The Paris-Sud University Lung Transplantation Group. Ann Thorac Surg. 1995;60:1597–1604

115. Yu P, Clayman GL, Walsh GL. Long-term outcomes of microsurgical reconstruction for large tracheal defects. Cancer. 2011;117:802–808

116. Gilbert RW, Neligan PC. Microsurgical laryngotracheal reconstruction. Clin Plast Surg. 2005;32:293–301, v
117. Al-Khudari S, Sharma S, Young W, et al. Osteocutaneous radial forearm reconstruction of large partial cricotracheal defects. Head Neck. 2013;35:E254–E257

118. Maciejewski A, Szymczyk C, Półtorak S, et al. Tracheal reconstruction with the use of radial forearm free flap combined with biodegradative mesh suspension. Ann Thorac Surg. 2009;87:608–610

119. Caliceti U, Piccin O, Cavicchi O, et al. Anterolateral thigh free flap for tracheal reconstruction after parastomal recurrence. Head Neck. 2009;31:1107–1111

120. Park CW, Miles BA. The expanding role of the anterolateral thigh free flap in head and neck reconstruction. Curr Opin Otolaryngol Head Neck Surg. 2011;19:263–268

121. Icibaci A, de Mello-Filho FV. Tracheal transplant with a prefabricated microsurgical flap. Laryngoscope. 2009;119:2309–2314

122. Kashiwa K, Kobayashi S, Tono H, et al. Reconstruction of the cervical trachea using a prefabricated corticoperiosteal flap from the femur. Ann Plast Surg. 2009;62:633–636

123. Strome M, Stein J, Esclamado R, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med. 2001;344:1676–1679

124. Delaere P, Vranckx J, Verleden G, et al.Leuven Tracheal Transplant Group. Tracheal allotransplantation after withdrawal of immunosuppressive therapy. N Engl J Med. 2010;362:138–145

125. Yamaya M, Finkbeiner WE, Chun SY, et al. Differentiated structure and function of cultures from human tracheal epithelium. Am J Physiol. 1992;262(6, Part 1):L713–L724

126. Gray TE, Guzman K, Davis CW, et al. Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol. 1996;14:104–112

127. Yoon JH, Kim KS, Kim SS, et al. Secretory differentiation of serially passaged normal human nasal epithelial cells by retinoic acid: expression of mucin and lysozyme. Ann Otol Rhinol Laryngol. 2000;109:594–601

128. Sachs LA, Finkbeiner WE, Widdicombe JH. Effects of media on differentiation of cultured human tracheal epithelium. In Vitro Cell Dev Biol Anim. 2003;39:56–62

129. Chistiakov DA. Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation. J Biomed Sci. 2010;17:92

130. Igai H, Yamamoto Y, Chang SS, et al. Tracheal cartilage regeneration by slow release of basic fibroblast growth factor from a gelatin sponge. J Thorac Cardiovasc Surg. 2007;134:170–175

131. Igai H, Chang SS, Gotoh M, et al. Regeneration of canine tracheal cartilage by slow release of basic fibroblast growth factor from gelatin sponge. ASAIO J. 2006;52:86–91

132. Igai H, Chang SS, Gotoh M, et al. Tracheal cartilage regeneration and new bone formation by slow release of bone morphogenetic protein (BMP)-2. ASAIO J. 2008;54:104–108

133. Okamoto T, Yamamoto Y, Gotoh M, et al. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J Thorac Cardiovasc Surg. 2004;127:329–334

134. Gong YY, Xue JX, Zhang WJ, et al. A sandwich model for engineering cartilage with acellular cartilage sheets and chondrocytes. Biomaterials. 2011;32:2265–2273

135. Hong HJ, Lee JS, Choi JW, et al. Transplantation of autologous chondrocytes seeded on a fibrin/hyaluronan composite gel into tracheal cartilage defects in rabbits: preliminary results. Artif Organs. 2012;36:998–1006

136. Komura M, Komura H, Kanamori Y, et al. An animal model study for tissue-engineered trachea fabricated from a biodegradable scaffold using chondrocytes to augment repair of tracheal stenosis. J Pediatr Surg. 2008;43:2141–2146

137. Walles T, Giere B, Macchiarini P, et al. Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering. Ann Thorac Surg. 2004;78:444–448; discussion 448–449

138. Weidenbecher M, Tucker HM, Awadallah A, et al. Fabrication of a neotrachea using engineered cartilage. Laryngoscope. 2008;118:593–598

139. Lu Y, Adkisson HD, Bogdanske J, et al. In vivo transplantation of neonatal ovine neocartilage allografts: determining the effectiveness of tissue transglutaminase. J Knee Surg. 2005;18:31–42

140. Weinand C, Peretti GM, Adams SB Jr, et al. Healing potential of transplanted allogeneic chondrocytes of three different sources in lesions of the avascular zone of the meniscus: a pilot study. Arch Orthop Trauma Surg. 2006;126:599–605

141. Imaizumi M, Nomoto Y, Sato Y, et al. Evaluation of the use of induced pluripotent stem cells (iPSCs) for the regeneration of tracheal cartilage. Cell Transplant. 2013;22:341–353

142. Fishman JM, De Coppi P, Elliott MJ, et al. Airway tissue engineering. Expert Opin Biol Ther. 2011;11:1623–1635

143. Kim J, Suh SW, Shin JY, et al. Replacement of a tracheal defect with a tissue-engineered prosthesis: early results from animal experiments. J Thorac Cardiovasc Surg. 2004;128:124–129

144. Lee CJ, Moon KD, Choi H, et al. Tissue engineered tracheal prosthesis with acceleratedly cultured homologous chondrocytes as an alternative of tracheal reconstruction. J Cardiovasc Surg (Torino). 2002;43:275–279

145. Li Z, Zhang M. Chitosan-alginate as scaffolding material for cartilage tissue engineering. J Biomed Mater Res A. 2005;75:485–493
146. Yang L, Korom S, Welti M, et al. Tissue engineered cartilage generated from human trachea using DegraPol scaffold. Eur J Cardiothorac Surg. 2003;24:201–207

147. Britt JC, Park SS. Autogenous tissue-engineered cartilage: evaluation as an implant material. Arch Otolaryngol Head Neck Surg. 1998;124:671–677

148. Temenoff JS, Mikos AG. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials. 2000;21:2405–2412

149. Jungebluth P, Alici E, Baiguera S, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet. 2011;378:1997–2004

150. Sutherland RS, Baskin LS, Hayward SW, et al. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J Urol. 1996;156(2, Part 2):571–577

151. Galois L, Hutasse S, Cortial D, et al. Bovine chondrocyte behaviour in three-dimensional type I collagen gel in terms of gel contraction, proliferation and gene expression. Biomaterials. 2006;27:79–90

152. Sato M, Kikuchi M, Ishihara M, et al. Tissue engineering of the intervertebral disc with cultured annulus fibrosus cells using atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS scaffold). Med Biol Eng Comput. 2003;41:365–371

153. Macchiarini P, Walles T, Biancosino C, et al. First human transplantation of a bioengineered airway tissue. J Thorac Cardiovasc Surg. 2004;128:638–641

154. Macchiarini P, Jungebluth P, Go T, et al. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372:2023–2030

155. Bader A, Macchiarini P. Moving towards in situ tracheal regeneration: the bionic tissue engineered transplantation approach. J Cell Mol Med. 2010;14:1877–1889

156. Elliott MJ, De Coppi P, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. 2012;380:994–1000

157. Laurance J. British boy receives trachea transplant built with his own stem cells. BMJ. 2010;340:c1633

158. Baiguera S, Del Gaudio C, Jaus MO, et al. Long-term changes to in vitro preserved bioengineered human trachea and their implications for decellularized tissues. Biomaterials. 2012;33:3662–3672

159. Freed LE, Guilak F, Guo XE, et al. Advanced tools for tissue engineering: scaffolds, bioreactors, and signaling. Tissue Eng. 2006;12:3285–3305

160. Tan Q, Steiner R, Hoerstrup SP, et al. Tissue-engineered trachea: history, problems and the future. Eur J Cardiothorac Surg. 2006;30:782–786

161. Pörtner R, Nagel-Heyer S, Goepfert C, et al. Bioreactor design for tissue engineering. J Biosci Bioeng. 2005;100:235–245

162. Badylak SF, Weiss DJ, Caplan A, et al. Engineered whole organs and complex tissues. Lancet. 2012;379:943–952

163. Asnaghi MA, Jungebluth P, Raimondi MT, et al. A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: from concept to clinical trial. Biomaterials. 2009;30:5260–5269

164. Lin CH, Hsu SH, Huang CE, et al. A scaffold-bioreactor system for a tissue-engineered trachea. Biomaterials. 2009;30:4117–4126

165. Miller C, George S, Niklason L. Developing a tissue-engineered model of the human bronchiole. J Tissue Eng Regen Med. 2010;4:619–627

166. Tan Q, Hillinger S, van Blitterswijk CA, et al. Intra-scaffold continuous medium flow combines chondrocyte seeding and culture systems for tissue engineered trachea construction. Interact Cardiovasc Thorac Surg. 2009;8:27–30

167. Vunjak-Novakovic G, Martin I, Obradovic B, et al. Bioreactor cultivation conditions modulate the composition and mechanical properties of tissue-engineered cartilage. J Orthop Res. 1999;17:130–138

168. Kalathur M, Baiguera S, Macchiarini P. Translating tissue-engineered tracheal replacement from bench to bedside. Cell Mol Life Sci. 2010;67:4185–4196

169. Haykal S, Salna M, Zhou Y, et al. Double-chamber rotating bioreactor for dynamic perfusion cell seeding of large segment tracheal allografts: comparison to conventional static methods. Tissue Eng Part C Methods. 2014 Mar 5. [Epub ahead of print]

© 2014 American Society of Plastic Surgeons